Previous 10 | Next 10 |
DENTSPLY SIRONA Inc. (XRAY) Q4 2022 Earnings Conference Call February 28, 2023 08:30 AM ET Company Participants Andrea Daley - Vice President-Investor Relations Simon Campion - Chief Executive Officer Glenn Coleman - Chief Financial Officer Conference Call Partic...
The following slide deck was published by DENTSPLY SIRONA Inc. in conjunction with their 2022 Q4 earnings call. For further details see: DENTSPLY SIRONA Inc. 2022 Q4 - Results - Earnings Call Presentation
Dentsply Sirona press release ( NASDAQ: XRAY ): Q4 Non-GAAP EPS of $0.46 beats by $0.13 . Revenue of $983M (-9.8% Y/Y) beats by $43.89M . FY23 outlook: net sales of $3.85 - $3.95 billion, organic sales down (1%) to up 2%, adj. EPS range of $1.80 to $2.00 vs. ...
FY22 net sales decreased (7.3%) to $3,922 million , organic sales decreased (0.5%) FY22 GAAP EPS of ($4.41) , adjusted EPS of $2.09 Q4 net sales decreased (10.9%) to $983 million , organic sales decreased (2.6%)...
Dentsply Sirona ( NASDAQ: XRAY ) is scheduled to announce Q4 earnings results on Tuesday, February 28th, before market open. The consensus EPS Estimate is $0.33 (-56.6% Y/Y) and the consensus Revenue Estimate is $939.11M (-13.8% Y/Y). Over the last 2 years, XRAY has beaten E...
Dentsply Sirona ( NASDAQ: XRAY ) will undergo a organization restructuring that will save an anticipated $200M-$225M annually in cost savings. The dental products and technologies company will implement five global business units with the aim of aligning the product portfolio with its...
Expects to Achieve $200 to $225 million in Annual Cost Savings Portfolio Evaluation and Simplification Plan Ongoing CHARLOTTE, N.C., Feb. 16, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced...
Summary Dentsply Sirona has a new management team in place and more details on how they intend to improve operating results should be coming fairly soon. This business seems ripe for a portfolio review to pare out low-return/low-potential products and a restructuring of the global sales...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Dentsply Sirona, Inc. (NasdaqGS: XRAY). On April 19, 2022, the Company disclosed the sudden t...
CHARLOTTE, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Tuesday, February 28, 2023, at 8:30 am ET...
News, Short Squeeze, Breakout and More Instantly...
CHARLOTTE, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Wednesday, July 31, 2024, at 8:30 am ET to review its second q...
NASDAQ: XRAY Lawsuit Update: Investors who lost money with shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) should contact the the Shareholders Foundation PR Newswire SAN DIEGO , June 17, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced an update in ...
2024-06-15 19:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...